Opportunistic Infections in the Immunocompromised Patient
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 149
Special Issue Editors
Interests: host–pathogen interaction; infectious diseases; bioinformatics; virus evolution
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute your research to the following Special Issue: “Opportunistic Infections in the Immunocompromised Patient”.
Opportunistic infections in the immunocompromised patient constitute a serious threat that endangers the lives of many patients every year. Although it has been thought that immunocompromised patients constitute only a small fraction of the population, this is not the case. Acquired viral immunodeficiency, solid organ transplants, bone marrow transplants, cancerous neoplasms, hematological neoplasms, genetic conditions and immunosuppressive therapy are just some of the possible conditions that can cause the immune system to be unable to defend against opportunistic infections. Considering that the mortality rate of these infections in frail patients is much higher, it becomes easy to understand how studying these conditions in detail to better address them can be crucial for improving the expectation and quality of vision in frail patients.
This Special Issue will significantly contribute to shedding light on this problem with. With this in mind, we invite you to submit original research articles, comprehensive reviews, and short communications regarding, but are not limited to, the following topics:
- Global Epidemiology and Prevalence: Analysis of the distribution and prevalence of opportunistic infections in immunocompromised patients;
- Immunological Mechanisms: Studies exploring the molecular and cellular mechanisms behind pathogen–host interactions in compromised immune systems;
- Diagnostic and Therapeutic Innovations: Development of novel diagnostic approaches and therapeutic strategies for managing opportunistic infections;
- Prevention and Control Strategies: Identification of risk factors and assessment of preventive measures to mitigate the clinical impact of these infections;
- Clinical Outcomes: Evaluation of the clinical implications and complications arising from opportunistic infections in various immunocompromised patient populations.
We look forward to receiving your valuable contributions.
Dr. Domenico Benvenuto
Dr. Luca Navarini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunocompromised patients
- opportunistic infections
- infectious diseases
- HIV
- immunological mechanisms
- epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
